Worldwide Clinical Trials, Inc. has announced that it expanded its early phase clinical trial capabilities by opening its Bioanalytical Center of Excellence—a larger lab in Austin, TX. This investment builds on Worldwide’s recent addition of three key leadership roles and enables the company to optimally support preclinical and early phase development.
Read more about the new facility here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.